[A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria]. 1992

K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova

Augmentin suspension (amoxycillin+clavulanic acid) was estimated in clinico-laboratory studies with respect to children suffering from pyoinflammatory diseases of various localization and its high efficacy was shown. Good and satisfactory results were recorded in 96.3 per cent of the cases in the treatment (monotherapy) and afterwards in the patients, adverse reactions such as nausea and vomiting being recorded only in 1 patient. The therapy with augmentin led to normalization of the microflora of the upper respiratory tract mucosa and a 1.5-fold increase in the neutrophil engulfment index.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002969 Clavulanic Acids Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects. Acids, Clavulanic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005490 Focal Infection An infection at a specific location that may spread to another region of the body. Focal Infections,Infection, Focal,Infections, Focal

Related Publications

K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
January 1993, Stomatologiia,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
January 1991, Sovetskaia meditsina,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
March 1989, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
January 2000, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
February 1982, Pediatriia,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
January 1988, Klinicheskaia khirurgiia,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
January 1991, Stomatologiia,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
September 1992, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
August 1998, Journal of pediatric surgery,
K I Savitskaia, and A G Nekhorosheva, and L Z Skala, and V N Nasonov, and O E Solodilova, and A G Shanina, and E N Dutova
June 1973, Vestnik khirurgii imeni I. I. Grekova,
Copied contents to your clipboard!